Over the past 28 years, Stony Brook University’s Center for Biotechnology has developed more than a dozen commercially available [MORE]
“Lilly will provide no-cost access to phenotypic assay panel for external investigators.” Using parallel synthesis, a single investigator can generate [MORE]
Pfizer believes that its highest payoff for R&D will be in oncology, pain, inflammation, diabetes, Alzheimer’s’ disease and [MORE]